Hook: What happens when the “gold standard” stops working?
In the fight against ER+/HER2-ve Metastatic Breast Cancer, resistance is our biggest hurdle. Join ESMO President-Elect Prof. Giuseppe Curigliano (Italy) for an essential session: “Breaking the Cycle.”
Discover the next generation of strategies to bypass resistance and redefine the future of MBC therapy at Africa’s largest oncology platform.
Jan 22–23, 2026
Hilton Heliopolis, Cairo
Secure Your Spot: bgicc.net
BGICC: The Precision Medicine Revolution
